Giuseppe Leoncini - Concepedia

Author

Giuseppe Leoncini

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

G LEONCINI, G Leoncini, G. LEONCINI, G. Leoncini, Giuseppe LEONCINI, Giuseppe Leoncini

Publications

940

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Casa di Cura Villa Garda Istituti di Ricovero e Cura a Carattere Scientifico Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Azienda Socio Sanitaria Territoriale del Garda

About

Giuseppe Leoncini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, pathology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	457
2	Gastroenterology	6	6	222
3	Anatomy	2	2	33
4	Health Sciences	1	1	18
5	Cell Biology	1	1	101

Giuseppe Leoncini

Publications

612

Citations

H-Index

Page 1

	Year	Citations
Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma Daniela Massi, Francesca Tarantini, Alessandro Franchi, Modern Pathology Cutaneous Malignant MelanomaSignal TransductionDifferential ExpressionMelanomaNotch Receptors	2005	101
INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC). Filippo Pietrantonio, Alessandra Raimondi, Sara Lonardi, Journal of Clinical Oncology Surgical OncologyCancer ManagementImmunologyGastroenterologyPathology	2023	90
Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors Paolo Manca, Francesca Corti, Rossana Intini, European Journal of Cancer MedicineImmune Checkpoint InhibitorsImmunologyColorectal CancerPathology	2023	50
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO A. Raimondi, Sara Lonardi, Sabina Murgioni, Annals of Oncology Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineInfinity Study	2024	50
Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases Joseph J. Zhao, Chin‐Ann Johnny Ong, Supriya Srivastava, Gastroenterology	2024	37
Histopathology of inflammatory bowel disease — Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC) Vincenzo Villanacci, Luca Reggiani Bonetti, Flavio Caprioli, Digestive and Liver Disease HistopathologyGastroenterologyPathologyClinical GastroenterologySurgery	2019	30
Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury? Marco Matucci‐Cerinic, Alberto Moggi Pignone, T. Lotti, PubMed Vascular DiseaseImmunologyPathologyEndothelial InjuryDermatology	1990	28
Mucin Expression Profiles in Ulcerative Colitis: New Insights on the Histological Mucosal Healing Giuseppe Leoncini, Luigi Cari, Simona Ronchetti, International Journal of Molecular Sciences	2024	28
Glandular hamartoma of the larynx: Report of a case Giuseppe Leoncini, Vincenza Maio, Lorenzo Mirabile, Auris Nasus Larynx Glandular HamartomaSurgical PathologyHistopathologyOtorhinolaryngologyLarynx	2007	23
Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy Giuseppe Leoncini, Vincenzo Villanacci, Maria Grazia Marin, Techniques in Coloproctology InflammationColonic HypereosinophiliaFunctional Gastrointestinal DisorderGastroenterologyPathology	2018	23

Page 1